Search

everythinglearnresearchcommunity

for

Search:↓

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

An elderly woman with cancer improved after treatment for a rare skin condition with coiled hairs.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.